NATX Plasmids, for: DNA Vaccines, Gene Therapeutics, Viral Vectors andBiophamacueticals

Corporate Profile
Management Team

NTC PRODUCTS AND SERVICES


VECTORS
X
Mammalian Vectors
XAntibiotic-Free Vecotrs
XRig-I Activating Vectors
XpDNAVACCUltra Vector
XLinear Vectors
XRecombineering Vectors
XAutolytic E. coli Cell Lines
XGene Sllencing (transient)
XGene Sllencing (retroviral, stable)
XAnti-Silencing Elements

CELL LINES
XAutolytic E. coli Cell Lines

DNA VACCINES
XXX
DNA Vaccine References
XXX
Pricing
XXXX
PRECISION CLONING
XX
Services and Pricing

RECOMBINANT PROTEINS
X
pVEX™
X
Fluorescent Proteins

PLASMIDS
XSmall Scale Plasmid DNA
XSmall Scale C of A
XLarge Scale Plasmid DNA
XLarge Scale C of A
XPlasmid DNA Order Form
XE. coli Cell paste
XPlasmid Detox Service, NEW!
X
DNA FERMENTATION PROCESS
X
HyperGRO™ Process
X
HyperGRO™ Licensing
X
HyperGRO™ Pricing

PROCESS DEVELOPMENT
X
Process Development Basics
X
Process Licensing

HYPERTAQ™ DNA POLYMERASE


NTC Contacts:

Email: support@natx.com
Phone: (402) 472-6530
Fax: (402) 472-6532

site map | home | contact us



Clague P. Hodgson, Ph.D.
Founder, Chief Executive Officer,
Gene Vectors
Clague Hodgson, NTC’s founder brings 20 years experience in basic and applied genetics research and lab management.  Clague previously held faculty positions at Creighton University School of Medicine and The Ohio State University. He was trained at the University of Minnesota (undergraduate and graduate), and at the Mayo Graduate School of Medicine (Ph.D.), with postdoctoral training at Baylor College of Medicine. He has published numerous scientific articles, book chapters, patents, and a book on gene therapy.

Jim Williams, Ph.D.
Chief Scientific Officer
Vice President for Research and Development

DNA Vaccines
Jim Williams, Ph.D., Joined NTC as Lead Scientist and VP, Research and Development, in August, 2002.  Jim’s expertise includes regulatory affairs, quality, molecular genetics, fermentation, and protein expression systems. Jim previously held key management and scientific positions at Restoragen (1997-2002) and at Ophidian Pharmaceuticals.  Jim received his Ph.D. in genetics (University of Alberta), and completed postdoctoral training at the University of Wisconsin.
Aaron Carnes, B.Sc.E.
Director Process Development
Plasmid Fermentation
Aaron Carnes, B.Sc.E., is a chemical engineer focusing on process development in the fields of fermentation and purification for high yield DNA production. Aaron holds a B.Sc.E. from the University of Nebraska at Lincoln.
Colleen S. Nygren
Human Resouces, Treasurer

Recombinant Proteins
Colleen Nygren is a graduate of the University of Nebraska School of Business. Colleen has worked in the accounting field for 20 years, with experience in brokerage, banking, and investment operations.
Kris Hodgson
Computer Graphics and Web Designer
Fermentation Media Kit
Kris Hodgson is co-founder of NTC and manages the NTC websites and marketing, including advertising, artwork, and electronic publications


Contact NTC, Toll free: 1-(888) WIZ-BANG

Plasmids, Recombinant Proteins, DNA Vaccines, Viral Vectors, Therapeutic Genes, Fermentation Technology for Gene Therapy and Biotechnology
NTC's free resource "Site" for the biotechnology industry,
including Databases and Sequences Analysis Tool
s



WWW http://www.natx.com